Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quantitative CT analysis of interstitial pneumonia in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: a single center, retrospective study.
Yamaguchi K, Nakajima T, Yamaguchi A, Itai M, Onuki Y, Shin Y, Uno S, Muto S, Kouno S, Yatomi M, Aoki-Saito H, Hara K, Endo Y, Motegi SI, Muro Y, Nakasatomi M, Sakairi T, Hiromura K, Katsumata N, Hirasawa H, Tsushima Y, Maeno T. Yamaguchi K, et al. Among authors: itai m. Clin Rheumatol. 2022 May;41(5):1473-1481. doi: 10.1007/s10067-021-06033-7. Epub 2022 Jan 16. Clin Rheumatol. 2022. PMID: 35034225
Clinical features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis complicated by spontaneous pneumomediastinum.
Yamaguchi K, Yamaguchi A, Itai M, Kashiwagi C, Takehara K, Aoki S, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Takemura M, Hara K, Motegi SI, Muro Y, Nakasatomi M, Sakairi T, Hiromura K, Kurabayashi M, Maeno T. Yamaguchi K, et al. Among authors: itai m. Clin Rheumatol. 2019 Dec;38(12):3443-3450. doi: 10.1007/s10067-019-04729-5. Epub 2019 Aug 16. Clin Rheumatol. 2019. PMID: 31420814
Clinical features of dermatomyositis associated with anti-MDA5 antibodies by age.
Yamaguchi K, Yamaguchi A, Onuki Y, Itai M, Kashiwagi C, Takehara K, Aoki S, Kanaya A, Taguchi K, Umetsu K, Oshima K, Uchida M, Kimura H, Kasahara M, Takemura M, Hara K, Sekiguchi A, Motegi SI, Muro Y, Nakasatomi M, Motohashi R, Sakairi T, Nakagawa J, Hiromura K, Obokata M, Kurabayashi M, Maeno T. Yamaguchi K, et al. Among authors: itai m. Mod Rheumatol. 2021 Jan;31(1):177-185. doi: 10.1080/14397595.2020.1740400. Epub 2020 Mar 30. Mod Rheumatol. 2021. PMID: 32149542
Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
Takemura M, Motegi M, Kuroiwa Y, Itai M, Taguchi K, Umetsu K, Uchida M, Kounoc S, Sato M, Masubuchi H, Yamaguchi A, Yamaguchi K, Ikeda K, Nakagawa J, Maeno T. Takemura M, et al. Among authors: itai m. Respir Med Case Rep. 2021 Feb 2;32:101361. doi: 10.1016/j.rmcr.2021.101361. eCollection 2021. Respir Med Case Rep. 2021. PMID: 33643837 Free PMC article.
Interstitial lung disease with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis in elderly patients.
Yamaguchi K, Yamaguchi A, Itai M, Onuki Y, Shin Y, Uno S, Hanazato C, Taguchi K, Umetsu K, Aikawa M, Kouno S, Takemura M, Hara K, Motegi S, Tsukida M, Ota F, Tsukada Y, Motegi M, Nakasatomi M, Sakairi T, Ikeuchi H, Kaneko Y, Hiromura K, Maeno T. Yamaguchi K, et al. Among authors: itai m. Rheumatol Int. 2021 Sep;41(9):1641-1650. doi: 10.1007/s00296-021-04891-7. Epub 2021 May 30. Rheumatol Int. 2021. PMID: 34056682
Influence of obesity in interstitial lung disease associated with anti-aminoacyl-tRNA synthetase antibodies.
Yamaguchi K, Fukushima Y, Yamaguchi A, Itai M, Shin Y, Uno S, Muto S, Kouno S, Tsurumaki H, Yatomi M, Aoki-Saito H, Hara K, Koga Y, Sunaga N, Endo Y, Motegi SI, Nakasatomi M, Sakairi T, Ikeuchi H, Hiromura K, Hisada T, Tsushima Y, Kuwana M, Maeno T. Yamaguchi K, et al. Among authors: itai m. Respir Med. 2022 Mar;193:106741. doi: 10.1016/j.rmed.2022.106741. Epub 2022 Jan 13. Respir Med. 2022. PMID: 35091206 Free article.
Clinical differences among patients with myeloperoxidase-antineutrophil cytoplasmic antibody-positive interstitial lung disease.
Yamaguchi K, Yamaguchi A, Ito M, Wakamatsu I, Itai M, Muto S, Uno S, Aikawa M, Kouno S, Takemura M, Yatomi M, Aoki-Saito H, Koga Y, Hara K, Motegi S, Tsukida M, Ota F, Tsukada Y, Motegi M, Nakasatomi M, Sakairi T, Ikeuchi H, Kaneko Y, Hiromura K, Maeno T. Yamaguchi K, et al. Among authors: itai m. Clin Rheumatol. 2023 Feb;42(2):479-488. doi: 10.1007/s10067-022-06388-5. Epub 2022 Oct 4. Clin Rheumatol. 2023. PMID: 36194347
Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib.
Yamaguchi O, Kasahara N, Soda H, Imai H, Naruse I, Yamaguchi H, Itai M, Taguchi K, Uchida M, Sunaga N, Maeno T, Minato K, Tomono H, Ogawara D, Mukae H, Miura Y, Shiono A, Mouri A, Kagamu H, Kaira K. Yamaguchi O, et al. Among authors: itai m. Sci Rep. 2023 Nov 27;13(1):20848. doi: 10.1038/s41598-023-48210-5. Sci Rep. 2023. PMID: 38012343 Free PMC article.
16 results